181 related articles for article (PubMed ID: 22203922)
1. Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.
Bălăcescu L; Bălăcescu O; Crişan N; Fetica B; Petruţ B; Bungărdean C; Rus M; Tudoran O; Meurice G; Irimie A; Dragoş N; Berindan-Neagoe I
Rom J Morphol Embryol; 2011; 52(4):1195-202. PubMed ID: 22203922
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
3. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
Reyes I; Tiwari R; Geliebter J; Reyes N
Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.
Halvorsen OJ; Oyan AM; Bø TH; Olsen S; Rostad K; Haukaas SA; Bakke AM; Marzolf B; Dimitrov K; Stordrange L; Lin B; Jonassen I; Hood L; Akslen LA; Kalland KH
Int J Oncol; 2005 Feb; 26(2):329-36. PubMed ID: 15645116
[TBL] [Abstract][Full Text] [Related]
6. Analysis of differentially expressed genes in LNCaP prostate cancer progression model.
Xie BX; Zhang H; Wang J; Pang B; Wu RQ; Qian XL; Yu L; Li SH; Shi QG; Huang CF; Zhou JG
J Androl; 2011; 32(2):170-82. PubMed ID: 20864652
[TBL] [Abstract][Full Text] [Related]
7. Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.
Nadiminty N; Dutt S; Tepper C; Gao AC
Prostate; 2010 Feb; 70(3):276-87. PubMed ID: 19827050
[TBL] [Abstract][Full Text] [Related]
8. A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.
Agell L; Hernández S; Nonell L; Lorenzo M; Puigdecanet E; de Muga S; Juanpere N; Bermudo R; Fernández PL; Lorente JA; Serrano S; Lloreta J
Am J Pathol; 2012 Nov; 181(5):1585-94. PubMed ID: 23083832
[TBL] [Abstract][Full Text] [Related]
9. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
Tamura K; Furihata M; Tsunoda T; Ashida S; Takata R; Obara W; Yoshioka H; Daigo Y; Nasu Y; Kumon H; Konaka H; Namiki M; Tozawa K; Kohri K; Tanji N; Yokoyama M; Shimazui T; Akaza H; Mizutani Y; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Res; 2007 Jun; 67(11):5117-25. PubMed ID: 17545589
[TBL] [Abstract][Full Text] [Related]
10. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
Schlomm T; Luebke AM; Sültmann H; Hellwinkel OJ; Sauer U; Poustka A; David KA; Chun FK; Haese A; Graefen M; Erbersdobler A; Huland H
Int J Oncol; 2005 Sep; 27(3):713-20. PubMed ID: 16077921
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.
Stamey TA; Warrington JA; Caldwell MC; Chen Z; Fan Z; Mahadevappa M; McNeal JE; Nolley R; Zhang Z
J Urol; 2001 Dec; 166(6):2171-7. PubMed ID: 11696729
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model.
Balaji KC; Rao PS; Smith DJ; Louis S; Smith LM; Sherman S; Bacich D; O'Keefe D
Urol Oncol; 2004; 22(4):313-20. PubMed ID: 15283889
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.
Xu J; Stolk JA; Zhang X; Silva SJ; Houghton RL; Matsumura M; Vedvick TS; Leslie KB; Badaro R; Reed SG
Cancer Res; 2000 Mar; 60(6):1677-82. PubMed ID: 10749139
[TBL] [Abstract][Full Text] [Related]
14. GREB1 tissue expression is associated with organ-confined prostate cancer.
Antunes AA; Leite KR; Reis ST; Sousa-Canavez JM; Camara-Lopes LH; Dall'oglio MF; Srougi M
Urol Oncol; 2012; 30(1):16-20. PubMed ID: 19945309
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
16. [Molecular analysis for prostate cancer].
Ueda T; Suzuki H; Ichikawa T
Nihon Rinsho; 2005 Feb; 63(2):213-7. PubMed ID: 15714968
[TBL] [Abstract][Full Text] [Related]
17. Microarray-based expression profiling in prostate tumors.
Elek J; Park KH; Narayanan R
In Vivo; 2000; 14(1):173-82. PubMed ID: 10757075
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer.
Waghray A; Schober M; Feroze F; Yao F; Virgin J; Chen YQ
Cancer Res; 2001 May; 61(10):4283-6. PubMed ID: 11358857
[TBL] [Abstract][Full Text] [Related]
19. The significance of LMO2 expression in the progression of prostate cancer.
Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
[TBL] [Abstract][Full Text] [Related]
20. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
